168 related articles for article (PubMed ID: 25108345)
1. Effect of gemcitabine and retinoic acid loaded PAMAM dendrimer-coated magnetic nanoparticles on pancreatic cancer and stellate cell lines.
Yalçin S; Erkan M; Ünsoy G; Parsian M; Kleeff J; Gündüz U
Biomed Pharmacother; 2014 Jul; 68(6):737-43. PubMed ID: 25108345
[TBL] [Abstract][Full Text] [Related]
2. Half generations magnetic PAMAM dendrimers as an effective system for targeted gemcitabine delivery.
Parsian M; Mutlu P; Yalcin S; Tezcaner A; Gunduz U
Int J Pharm; 2016 Dec; 515(1-2):104-113. PubMed ID: 27725272
[TBL] [Abstract][Full Text] [Related]
3. Effective targeting of gemcitabine to pancreatic cancer through PEG-cored Flt-1 antibody-conjugated dendrimers.
Öztürk K; Esendağlı G; Gürbüz MU; Tülü M; Çalış S
Int J Pharm; 2017 Jan; 517(1-2):157-167. PubMed ID: 27965135
[TBL] [Abstract][Full Text] [Related]
4. FGF2 engineered SPIONs attenuate tumor stroma and potentiate the effect of chemotherapy in 3D heterospheroidal model of pancreatic tumor.
Mardhian DF; Vrynas A; Storm G; Bansal R; Prakash J
Nanotheranostics; 2020; 4(1):26-39. PubMed ID: 31911892
[TBL] [Abstract][Full Text] [Related]
5. Metformin-Induced Stromal Depletion to Enhance the Penetration of Gemcitabine-Loaded Magnetic Nanoparticles for Pancreatic Cancer Targeted Therapy.
Han H; Hou Y; Chen X; Zhang P; Kang M; Jin Q; Ji J; Gao M
J Am Chem Soc; 2020 Mar; 142(10):4944-4954. PubMed ID: 32069041
[TBL] [Abstract][Full Text] [Related]
6. Targeting Pancreatic Cancer Cells and Stellate Cells Using Designer Nanotherapeutics in vitro.
Elechalawar CK; Hossen MN; Shankarappa P; Peer CJ; Figg WD; Robertson JD; Bhattacharya R; Mukherjee P
Int J Nanomedicine; 2020; 15():991-1003. PubMed ID: 32103952
[TBL] [Abstract][Full Text] [Related]
7. Development of poly (I:C) modified doxorubicin loaded magnetic dendrimer nanoparticles for targeted combination therapy.
Khodadust R; Unsoy G; Gunduz U
Biomed Pharmacother; 2014 Oct; 68(8):979-87. PubMed ID: 25458787
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effects of all-trans retinoic acid and its synergism with gemcitabine are associated with downregulation of p21-activated kinases in pancreatic cancer.
Wang K; Baldwin GS; Nikfarjam M; He H
Am J Physiol Gastrointest Liver Physiol; 2019 May; 316(5):G632-G640. PubMed ID: 30844294
[TBL] [Abstract][Full Text] [Related]
9. UTMD-Promoted Co-Delivery of Gemcitabine and miR-21 Inhibitor by Dendrimer-Entrapped Gold Nanoparticles for Pancreatic Cancer Therapy.
Lin L; Fan Y; Gao F; Jin L; Li D; Sun W; Li F; Qin P; Shi Q; Shi X; Du L
Theranostics; 2018; 8(7):1923-1939. PubMed ID: 29556365
[TBL] [Abstract][Full Text] [Related]
10. Anti-stromal treatment together with chemotherapy targets multiple signalling pathways in pancreatic adenocarcinoma.
Carapuça EF; Gemenetzidis E; Feig C; Bapiro TE; Williams MD; Wilson AS; Delvecchio FR; Arumugam P; Grose RP; Lemoine NR; Richards FM; Kocher HM
J Pathol; 2016 Jul; 239(3):286-96. PubMed ID: 27061193
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Gemcitabine Loaded Polyhydroxybutyrate Coated Magnetic Nanoparticles for Targeted Drug Delivery.
Parsian M; Mutlu P; Yalcin S; Gunduz U
Anticancer Agents Med Chem; 2020; 20(10):1233-1240. PubMed ID: 32156242
[TBL] [Abstract][Full Text] [Related]
12. Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer.
Lee GY; Qian WP; Wang L; Wang YA; Staley CA; Satpathy M; Nie S; Mao H; Yang L
ACS Nano; 2013 Mar; 7(3):2078-89. PubMed ID: 23402593
[TBL] [Abstract][Full Text] [Related]
13. Nano-targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo.
Mardhian DF; Storm G; Bansal R; Prakash J
J Control Release; 2018 Nov; 290():1-10. PubMed ID: 30287265
[TBL] [Abstract][Full Text] [Related]
14. Gemcitabine-retinoid prodrug loaded nanoparticles display in vitro antitumor efficacy towards drug-resilient human PANC-1 pancreatic cancer cells.
Kakwere H; Ingham ES; Tumbale SK; Ferrara KW
Mater Sci Eng C Mater Biol Appl; 2020 Dec; 117():111251. PubMed ID: 32919625
[TBL] [Abstract][Full Text] [Related]
15. Multifunctionalized iron oxide nanoparticles for selective targeting of pancreatic cancer cells.
Trabulo S; Aires A; Aicher A; Heeschen C; Cortajarena AL
Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1597-1605. PubMed ID: 28161480
[TBL] [Abstract][Full Text] [Related]
16. Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells.
Amrutkar M; Aasrum M; Verbeke CS; Gladhaug IP
BMC Cancer; 2019 Jun; 19(1):596. PubMed ID: 31208372
[TBL] [Abstract][Full Text] [Related]
17. Designing Liposomes To Suppress Extracellular Matrix Expression To Enhance Drug Penetration and Pancreatic Tumor Therapy.
Ji T; Lang J; Wang J; Cai R; Zhang Y; Qi F; Zhang L; Zhao X; Wu W; Hao J; Qin Z; Zhao Y; Nie G
ACS Nano; 2017 Sep; 11(9):8668-8678. PubMed ID: 28806504
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt-β-catenin signaling to slow tumor progression.
Froeling FE; Feig C; Chelala C; Dobson R; Mein CE; Tuveson DA; Clevers H; Hart IR; Kocher HM
Gastroenterology; 2011 Oct; 141(4):1486-97, 1497.e1-14. PubMed ID: 21704588
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Induced Myeloid Cells Are Reduced by Gemcitabine-Loaded PAMAM Dendrimers Decorated with Anti-Flt1 Antibody.
Yoyen-Ermis D; Ozturk K; Kursunel MA; Aydin C; Ozkazanc D; Gurbuz MU; Uner A; Tulu M; Calis S; Esendagli G
Mol Pharm; 2018 Apr; 15(4):1526-1533. PubMed ID: 29481086
[TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide-loaded nanoparticles enhance the chemosensitivity of gemcitabine in pancreatic cancer
Zhao Y; Yao H; Yang K; Han S; Chen S; Li Y; Chen S; Huang K; Lian G; Li J
Biomater Sci; 2022 Oct; 10(20):5989-6002. PubMed ID: 36052559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]